申请人:——
公开号:US20030105079A1
公开(公告)日:2003-06-05
The present invention relates to novel 1,2- or 1,3-diamine and amide compounds and pharmaceutically useful salts thereof and methods for treating central nervous system diseases. The present 1,2- or 1,3-diamine and amide compounds have high binding affinity to the sigma receptor.
本发明涉及新型的1,2-或1,3-二胺和酰胺化合物及其具有药用价值的盐,并提供了治疗中枢神经系统疾病的方法。本发明的1,2-或1,3-二胺和酰胺化合物具有高亲和力与sigma受体结合。